EUVIMEDEUVIMED entdecken
Crossref

PROGNOSTIC VALUE OF INFLAMMATORY AND IMMUNE INDICES IN NEOADJUVANT CONCURRENT CHEMORADIOTHERAPY FOR ESOPHAGEAL CANCER AT K HOSPITAL

Toàn Phạm, Xuân Võ, Bách Trần, Toàn Phạm

Tạp chí Ung thư học Việt Nam · 15.04.2026

DOI: 10.70755/vnjo.2026.82.2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Tạp chí Ung thư học Việt Nam, online erschienen am 15.04.2026. Verfasst von Toàn Phạm und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To evaluate the prognostic value of inflammatory–immune indices in patients with esophageal cancer treated with concurrent neoadjuvant chemoradiotherapy at K Hospital.



Subjects and Methods: This retrospective longitudinal study included 57 patients with middle-to-lower thoracic esophageal cancer, histologically confirmed squamous cell carcinoma, stage II–III according to the 8th edition of the AJCC staging system, who were treated with concurrent neoadjuvant chemoradiotherapy at K Hospital from January 2018 to December 2024. Clinical characteristics, paraclinical findings, treatment-related variables, and the NLR(Neutrophil/Lymphocyte), PLR(Platelet/Lymphocyte), and SII indices were collected. Optimal cut-off values were determined using time-dependent ROC curves based on mortality endpoints and the Youden index. Overall survival was analyzed using the Kaplan–Meier method, log-rank test, ROC analysis, and Cox regression.

Results

The median overall survival was 57 months; 3-year and 5-year overall survival rates were 73.3% and 41.9%, respectively. The optimal cut-off values for NLR, PLR, and SII were 5.3, 174.3, and 979.3. Patients with low SII had longer median survival than those with high SII (60 vs. 36 months; p=0.001). SII predicted 3-year overall survival with an AUC of 0.669 (p=0.035). In multivariable analysis, age >=60 years and nodal positivity were independent adverse prognostic factors, whereas low SII was an independent favorable prognostic factor (HR=0.131; 95% CI: 0.024-0.701; p=0.018).

Conclusions

Post-nCRT preoperative SII is a simple and clinically applicable index with prognostic value for overall survival in patients with locally advanced esophageal squamous cell carcinoma treated with neoadjuvant concurrent chemoradiotherapy.

Zitieren

APA

Phạm, T., Võ, X., Trần, B., & Phạm, T. (2026). PROGNOSTIC VALUE OF INFLAMMATORY AND IMMUNE INDICES IN NEOADJUVANT CONCURRENT CHEMORADIOTHERAPY FOR ESOPHAGEAL CANCER AT K HOSPITAL. Tạp chí Ung thư học Việt Nam. https://doi.org/10.70755/vnjo.2026.82.2

Vancouver

Phạm T, Võ X, Trần B, Phạm T. PROGNOSTIC VALUE OF INFLAMMATORY AND IMMUNE INDICES IN NEOADJUVANT CONCURRENT CHEMORADIOTHERAPY FOR ESOPHAGEAL CANCER AT K HOSPITAL. Tạp chí Ung thư học Việt Nam. 2026. doi:10.70755/vnjo.2026.82.2

BibTeX
@article{Phm2026,
  author = {Phạm, Toàn and Võ, Xuân and Trần, Bách and Phạm, Toàn},
  title = {PROGNOSTIC VALUE OF INFLAMMATORY AND IMMUNE INDICES IN NEOADJUVANT CONCURRENT CHEMORADIOTHERAPY FOR ESOPHAGEAL CANCER AT K HOSPITAL},
  journal = {Tạp chí Ung thư học Việt Nam},
  year = {2026},
  doi = {10.70755/vnjo.2026.82.2}
}
Kostenlos starten →